FDA proposes new rules for heart defibrillators

(AP)—The Food and Drug Administration will require makers of heart-zapping defibrillators to submit more data on their safety and effectiveness following years of recalls of the emergency devices.

Defibrillators use electric shocks to jolt the heart back to normal after patients collapse from . Once used exclusively in emergency rooms, they are now found in schools, office buildings and other public places.

The devices have been plagued by design and manufacturing flaws for years. The says it has received 45,000 reports of problems with defibrillators between 2005 and 2012.

Currently the FDA approves defibrillators through a fast-track process reserved for devices similar to ones already on the market.

The FDA proposal, when finalized, will require manufacturers to submit more extensive testing documentation before new defibrillators can be marketed.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA wants stricter testing for defibrillators

Jan 21, 2011

(AP) -- The Food and Drug Administration is recommending stricter safety measures for heart-zapping defibrillators after years of increasing problems with the emergency medical devices.

Heart defibrillator company signs decree

May 01, 2008

The U.S. Food and Drug Administration said Medtronic Inc. has agreed to comply with FDA rules in manufacturing its external heart defibrillators.

Welch Allyn AED-10 defibrillators recalled

Nov 07, 2007

The U.S. Food and Drug Administration announced the recall of Welch Allyn AED-10 automatic external defibrillators due to possibly defective circuit boards.

Recommended for you

Adrenal sex hormone level may predict heart disease risk

23 hours ago

(HealthDay)—Blood levels of the adrenal sex hormone dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S) may predict an increased risk of coronary heart disease (CHD) in elderly men, according to a study ...

Researchers aim to simplify life saving drug

Oct 29, 2014

Heparin, the life saving blood thinner used in major surgeries and treatment of heart diseases, is a complicated drug but a research team from the University of British Columbia has set out to make its use a lot safer by ...

Frequent readmissions, high costs after cardiac arrest

Oct 29, 2014

(HealthDay)—Frequent readmissions and high inpatient costs are seen among older survivors of in-hospital cardiac arrest, according to a study published online Oct. 28 in Circulation: Cardiovascular Quality an ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.